Examine This Report on Doxepin
glycerol phenylbutyrate will decrease the extent or result of triazolam by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of. Glycerol phenylbutyrate is a weak inducer of CYP3A4. Watch for lowered efficacy of CYP3A4 substrates that have a slender therapeutic index.